NCT06792617

Brief Summary

Short-term and long-term consequences of severe cardiac and/or lung dysfunction can be increased use of sedation, prolonged bedrest and immobility causing severe loss of muscle mass which could be a risk for muscle weakness, osteoporosis, and lowered endurance. The goal of this study is to show how a structured rehabilitation program can exhibit better short-term and long-term outcomes on patients who are treated with extracorporeal membrane oxygenation (ECMO).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Oct 2024

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 25, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 15, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 24, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 24, 2025

Status Verified

January 1, 2025

Enrollment Period

6 months

First QC Date

January 15, 2025

Last Update Submit

January 21, 2025

Conditions

Keywords

Extracorporeal membrane oxygenation (ECMO)Rehabilitation exercise program

Outcome Measures

Primary Outcomes (1)

  • Timing of exercises

    Time spent exercising per each session of rehabilitation program

    From enrollment to 3-month follow-up

Secondary Outcomes (8)

  • Mobility

    From enrollment to 3-month follow-up

  • Mobility

    From enrollment to 3-month follow-up

  • Mobility

    From enrollment to 3-month follow-up

  • Mobility

    From enrollment to 3-month follow-up

  • Mobility

    From enrollment to 3-month follow-up

  • +3 more secondary outcomes

Other Outcomes (1)

  • Quality of Life (QOL)

    From enrollment to 3-month follow-up

Study Arms (1)

Exercise Group

OTHER

The exercise group will complete the highest intensity exercise and activity as tolerated to maximize their progression of strength, function, and out of bed. This group will also be utlizing the VitalGo Total Lift Bed (TLB) V5 for vertical positioning to provide a better potential for hemodynamic response to activities to include: strength training, mobility tasks, and functional activities like Activities of Daily Living (ADL).

Other: Mobility (Central or Femoral Cannulation)Other: Resistance Training

Interventions

Functional Mobility \& ADL's 1. Assisted sitting with progression to unassisted; ADL's 2. Assisted standing with progression to unassisted; ADL's 1. VitalGo bed will be used if unsafe/unable to perform assisted standing. 2. Leg press (VitalGo bed) 3. Ambulation; ADL's

Exercise Group

Repetitions will be counted and documented per session per structured exercise.

Exercise Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>or equal to 18 years old
  • On ECMO (VV and/or VA) for cardiopulmonary dysfunction/failure
  • Admitted to Lung Recovery Intensive Care Unit (LRICU) or Cardiovascular Intensive Care Unit (CVICU).
  • Richmond Agitation and Sedation Scale (RASS) greater than or equal to a score of -2 or greater.

You may not qualify if:

  • Hemodynamically unstable as determined by clinical care team (including but not limited to: oxygen saturation \<90%, below target range of mean arterial pressure despite vasoactive or mechanical support, prone positioning, use of mechanical assist device (such as the intra-aortic balloon pump \[IABP\] or ventricular assist device \[VAD\]), active management of intracranial hypertension with abnormal intracranial pressure, spinal precautions, uncontrolled seizures, unstable major fracture, large open surgical wound, known controlled active bleeding).
  • Unable to utilize the VitalGo Total Lift BedTM (TLB, Catalog No. V5, Miramar FL) (e.g., height restrictions \[\>228 cm\], weight restrictions \[\>425 lbs\])
  • Pregnant or breast feeding.
  • Anticipated transfer to another hospital within 72 hours.
  • Not anticipated to survive more than 24 hours.
  • Unable to obtain informed consent from either patient or legally authorized representative (LAR).
  • Patients in the ICU but not on ECMO upon enrollment.
  • Patients actively awaiting transplant (heart/lung) without potential for weaning from ECMO.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Methodist Healthcare System

San Antonio, Texas, 78229, United States

Location

Related Publications (7)

  • Kang D, Lim J, Kim BG, Nam H, Kim Y, Kang E, Kim S, Shim S, Lee M, Yoon J, Lee H, Shin SH, Park HY, Cho J. Psychometric validation of the Korean Patient-Reported Outcome Measurement Information System (PROMIS)-29 Profile V2.1 among patients with chronic pulmonary diseases. J Thorac Dis. 2021 Oct;13(10):5752-5764. doi: 10.21037/jtd-21-591.

    PMID: 34795924BACKGROUND
  • Fisher CJ, Namas R, Seelman D, Jaafar S, Homer K, Wilhalme H, Young A, Nagaraja V, White ES, Schiopu E, Flaherty K, Khanna D. Reliability, construct validity and responsiveness to change of the PROMIS-29 in systemic sclerosis-associated interstitial lung disease. Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):49-56. Epub 2019 Sep 4.

    PMID: 31498073BACKGROUND
  • Eggmann S, Verra ML, Luder G, Takala J, Jakob SM. Effects of early, combined endurance and resistance training in mechanically ventilated, critically ill patients: A randomised controlled trial. PLoS One. 2018 Nov 14;13(11):e0207428. doi: 10.1371/journal.pone.0207428. eCollection 2018.

    PMID: 30427933BACKGROUND
  • Hayes K, Holland AE, Pellegrino VA, Young M, Paul E, Hodgson CL. Early rehabilitation during extracorporeal membrane oxygenation has minimal impact on physiological parameters: A pilot randomised controlled trial. Aust Crit Care. 2021 May;34(3):217-225. doi: 10.1016/j.aucc.2020.07.008. Epub 2020 Oct 7.

    PMID: 33039302BACKGROUND
  • Hayes K, Holland AE, Pellegrino VA, Mathur S, Hodgson CL. Acute skeletal muscle wasting and relation to physical function in patients requiring extracorporeal membrane oxygenation (ECMO). J Crit Care. 2018 Dec;48:1-8. doi: 10.1016/j.jcrc.2018.08.002. Epub 2018 Aug 7.

    PMID: 30118978BACKGROUND
  • Batycka-Stachnik D, Piwoda A, Darocha T, Spiewak M, Kosinski S, Jarosz A, Hymczak H, Sanak T, Galazkowski R, Piatek J, Konstanty-Kalandyk J, Drwila R. Problems and challenges in the early period of rehabilitating patients with severe hypothermia treated using ecmo support. Wiad Lek. 2016;69(3 pt 2):489-494.

    PMID: 27717931BACKGROUND
  • Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.

    PMID: 26903337BACKGROUND

MeSH Terms

Interventions

Range of Motion, ArticularMulticenter Studies as TopicResistance Training

Intervention Hierarchy (Ancestors)

Physical ExaminationDiagnostic Techniques and ProceduresDiagnosisMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaEpidemiologic Study CharacteristicsEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthExercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovement

Study Officials

  • Linda E Sousse, PhD, MBA

    Institute for Extracorporeal Life Support

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: The investigators will conduct a prospective clinical trial on eligible adults (≥18 years) with severe cardiac and/or lung dysfunction placed on ECMO. Results will be compared to historical controls from MHS who have not been enrolled in a rehabilitation program, which is the current standard of care (SOC).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Research

Study Record Dates

First Submitted

January 15, 2025

First Posted

January 24, 2025

Study Start

October 25, 2024

Primary Completion

May 1, 2025

Study Completion

December 1, 2025

Last Updated

January 24, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations